⌘K

Login Start Free

Home/Filings/4/0000899243-19-005457

4//SEC Filing

RIGBY JONATHAN 4

Accession 0000899243-19-005457

CIK 0001346302other

View on SEC.gov Company Profile

Filed

Feb 28, 7:00 PM ET

Accepted

Mar 1, 4:35 PM ET

Size

5.3 KB

Accession

0000899243-19-005457

Insider Transaction Report

Form 4

Period: 2019-02-27

XERIS PHARMACEUTICALS INCXERS

Director

Transactions

Award
Stock Option (right to buy)
2019-02-27+20,000→ 20,000 total
Exercise: $10.00Exp: 2029-02-27→ Common Stock (20,000 underlying)

Footnotes (1)

[F1]25% of these shares shall vest on the first anniversary of the vesting commencement date, with the remainder vesting ratably over the following 36 months.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

XERIS PHARMACEUTICALS INC

CIK 0001346302

Entity typeother

Related Parties

1

filerCIK 0001356227

Filing Metadata

Form type: 4
Filed: Feb 28, 7:00 PM ET
Accepted: Mar 1, 4:35 PM ET
Size: 5.3 KB

View on SEC.gov